• Je něco špatně v tomto záznamu ?

Multidisciplinary approach in the treatment of spinal dural arteriovenous fistula-results of endovascular and surgical treatment

T. Česák, J. Adamkov, P. Poczos, M. Kanta, A. Krajina, D. Krajíčková, R. Herzig, M. Vališ,

. 2018 ; 160 (12) : 2439-2448. [pub] 20180918

Jazyk angličtina Země Rakousko

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19045244

Grantová podpora
RVO - FN HK 00179906 Ministerstvo Zdravotnictví Ceské Republiky - International
PROGRES Q40 Charles University - International

E-zdroje Online Plný text

NLK ProQuest Central od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-01-01 do Před 1 rokem

BACKGROUND: The results of treatment for spinal dural arteriovenous fistula (SDAVF) have been controversial. The goal of this study was to compare results of endovascular and surgical treatments to contribute to determining an optimal treatment strategy. METHODS: A retrospective analysis of the set of 24 SDAVF patients (11 in the endovascular and 13 in the surgical group) was performed. The clinical effect (using the modified Rankin scale [mRS]), the radicality, and the number of clinical recurrences as well as the impact of age, the level of impairment, and the duration of symptoms before the treatment were evaluated. RESULTS: The average age was 60.1 ± 8.4 years. The median duration of symptoms before establishing a diagnosis was 12 (1-70) months. Clinical improvement was reported in 11 out of 24 (45.8%) patients (36.4% following embolization and 53.8% following surgery, p = 0.444). Radical performance was achieved in 47.4% of endovascular versus 92.9% of surgical procedures (p = 0.009). Clinical recurrence was reported in 35.3% of patients in the endovascular group, whereas no clinical recurrence was reported in the surgical group (p = 0.0133). The graphical residuum after 1 surgery out of 14 (7.1%) was cured early during the control angiography. Clinical improvement was reported 42.1% of patients with mRS ≤ 3 versus 60% of patients with mRS ≥ 4 and, in 57.1% of patients aged ≥ 60 versus in 30% of patients < 60 years (p > 0.05 in both cases). The impact of the duration of symptoms on the clinical results was not statistically significant. CONCLUSIONS: The surgical treatment of SDAVF appeared to be a more efficient method in terms of the clinical effect, radicality, and lower recurrence rate in comparison with the endovascular treatment. No statistically significant dependence of the clinical result on age, deficit burden, or symptom duration was found.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045244
003      
CZ-PrNML
005      
20200113081940.0
007      
ta
008      
200109s2018 au f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00701-018-3672-z $2 doi
035    __
$a (PubMed)30225811
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a au
100    1_
$a Česák, T $u Department of Neurosurgery, Comprehensive Stroke Center, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic.
245    10
$a Multidisciplinary approach in the treatment of spinal dural arteriovenous fistula-results of endovascular and surgical treatment / $c T. Česák, J. Adamkov, P. Poczos, M. Kanta, A. Krajina, D. Krajíčková, R. Herzig, M. Vališ,
520    9_
$a BACKGROUND: The results of treatment for spinal dural arteriovenous fistula (SDAVF) have been controversial. The goal of this study was to compare results of endovascular and surgical treatments to contribute to determining an optimal treatment strategy. METHODS: A retrospective analysis of the set of 24 SDAVF patients (11 in the endovascular and 13 in the surgical group) was performed. The clinical effect (using the modified Rankin scale [mRS]), the radicality, and the number of clinical recurrences as well as the impact of age, the level of impairment, and the duration of symptoms before the treatment were evaluated. RESULTS: The average age was 60.1 ± 8.4 years. The median duration of symptoms before establishing a diagnosis was 12 (1-70) months. Clinical improvement was reported in 11 out of 24 (45.8%) patients (36.4% following embolization and 53.8% following surgery, p = 0.444). Radical performance was achieved in 47.4% of endovascular versus 92.9% of surgical procedures (p = 0.009). Clinical recurrence was reported in 35.3% of patients in the endovascular group, whereas no clinical recurrence was reported in the surgical group (p = 0.0133). The graphical residuum after 1 surgery out of 14 (7.1%) was cured early during the control angiography. Clinical improvement was reported 42.1% of patients with mRS ≤ 3 versus 60% of patients with mRS ≥ 4 and, in 57.1% of patients aged ≥ 60 versus in 30% of patients < 60 years (p > 0.05 in both cases). The impact of the duration of symptoms on the clinical results was not statistically significant. CONCLUSIONS: The surgical treatment of SDAVF appeared to be a more efficient method in terms of the clinical effect, radicality, and lower recurrence rate in comparison with the endovascular treatment. No statistically significant dependence of the clinical result on age, deficit burden, or symptom duration was found.
650    _2
$a senioři $7 D000368
650    _2
$a cévní malformace centrálního nervového systému $x chirurgie $x terapie $7 D020785
650    _2
$a terapeutická embolizace $x škodlivé účinky $x metody $7 D004621
650    _2
$a endovaskulární výkony $x škodlivé účinky $x metody $7 D057510
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neurochirurgické výkony $x škodlivé účinky $x metody $7 D019635
650    _2
$a pooperační komplikace $x epidemiologie $7 D011183
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Adamkov, J $u Department of Neurosurgery, Comprehensive Stroke Center, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic.
700    1_
$a Poczos, P $u Department of Neurosurgery, Comprehensive Stroke Center, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic.
700    1_
$a Kanta, M $u Department of Neurosurgery, Comprehensive Stroke Center, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic.
700    1_
$a Krajina, A $u Department of Radiology, Comprehensive Stroke Center, Charles University Faculty of Medicine and University Hospital, Hradec Králové, Czech Republic.
700    1_
$a Krajíčková, D $u Department of Neurology, Comprehensive Stroke Center, Faculty of Medicine and University Hospital, Charles University in Prague, Hradec Králové, Czech Republic.
700    1_
$a Herzig, R $u Department of Neurology, Comprehensive Stroke Center, Faculty of Medicine and University Hospital, Charles University in Prague, Hradec Králové, Czech Republic.
700    1_
$a Vališ, Martin $u Department of Neurology, Comprehensive Stroke Center, Faculty of Medicine and University Hospital, Charles University in Prague, Hradec Králové, Czech Republic. martin.valis@fnhk.cz.
773    0_
$w MED00009022 $t Acta neurochirurgica $x 0942-0940 $g Roč. 160, č. 12 (2018), s. 2439-2448
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30225811 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200113082311 $b ABA008
999    __
$a ok $b bmc $g 1483513 $s 1083917
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 160 $c 12 $d 2439-2448 $e 20180918 $i 0942-0940 $m Acta neurochirurgica $n Acta Neurochir $x MED00009022
GRA    __
$a RVO - FN HK 00179906 $p Ministerstvo Zdravotnictví Ceské Republiky $2 International
GRA    __
$a PROGRES Q40 $p Charles University $2 International
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...